Adding Prandial Insulin to Basal Insulin Plus Oral Antidiabetic Drugs in Chinese Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Single-Arm Study

INTRODUCTION: There is relatively little data from China on the efficacy and safety of adding prandial insulin to basal insulin plus oral antidiabetic drugs (OADs) in people with poorly controlled type 2 diabetes mellitus (T2DM). This study assessed the efficacy and safety of basal insulin dose opti...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Yujing, Sun, Xiaowei, Zhao, Xichen, Zhu, Tiehong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446374/
https://www.ncbi.nlm.nih.gov/pubmed/28349442
http://dx.doi.org/10.1007/s13300-017-0247-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446374/
https://www.ncbi.nlm.nih.gov/pubmed/28349442
http://dx.doi.org/10.1007/s13300-017-0247-6

Ejemplares similares